AUTHOR=Guiot Julien , Henket Monique , Ernst Marie , Seidel Laurence , Winandy Marie , Denis Anna , Frix Anne-Noëlle , Gester Fanny , Thys Marie , Giltay Laurie , Garah Omaima , Njock Makon-Sébastien , Canivet Perrine , Meunier Paul , Corhay Jean-Louis , Regnier Céline , Malaise Olivier , Malaise Michel , Louis Renaud TITLE=Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis JOURNAL=Frontiers in Medicine VOLUME=10 YEAR=2023 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1063012 DOI=10.3389/fmed.2023.1063012 ISSN=2296-858X ABSTRACT=Objectives

In our study, we explored the specific subgroup of patients with rheumatoid arthritis (RA) suffering from obstructive lung disease (OLD) and its impact on morbi-mortality.

Methods

Our retrospective study included 309 patients suffering from RA with either obstructive (O-RA) or non-obstructive patterns (non-O-RA). OLD was defined based on the Tiffeneau index at the first available pulmonary functional test (PFT). Survival was then calculated and represented by a Kaplan–Meier curve. The comparison between the populations considered was performed by the Log-Rank test.

Results

Out of the 309 RA patients, 102 (33%) had airway obstruction. The overall survival time was significantly lower in the O-RA group than in the non-O-RA group (n = 207) (p < 0.001). The median survival time was 11.75 years in the O-RA group and higher than 16 years in the non-O-RA group. Multivariate analysis identified OLD as an independent risk factor for mortality (HR 2.20; 95% CI 1.21–4.00, p < 0.01).

Conclusion

Airway obstruction can be an independent risk factor of mortality in RA and should be considered as an early marker of poor prognosis. Further prospective longitudinal studies are required in order to determine the best clinical management for O-RA patients.